Age
Item
age 18-80 years
boolean
C0001779 (UMLS CUI [1])
Chronic Lymphocytic Leukemia
Item
histologically confirmed chronic lymphocytic leukemia
boolean
C0023434 (UMLS CUI [1])
White Blood Cell Count procedure
Item
leucocyte count more than 20 x 10 9/l
boolean
C0023508 (UMLS CUI [1])
Therapeutic procedure Lymphoma
Item
no other simultaneous treatment for lymphoma
boolean
C0087111 (UMLS CUI [1,1])
C0024299 (UMLS CUI [1,2])
Indication Therapeutic procedure Chronic Lymphocytic Leukemia
Item
no treatment indicated for chronic lymphocytic leukemia
boolean
C3146298 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0023434 (UMLS CUI [1,3])
WHO performance status scale
Item
who performance status 0-2
boolean
C1298650 (UMLS CUI [1])
HIV Seronegativity
Item
hiv negativity
boolean
C0019698 (UMLS CUI [1])
Hepatitis C virus Negative | Hepatitis B Surface Antigens | Antibody to hepatitis B core antigen | Communicable Diseases Uncontrolled
Item
negativity for hepatitis c virus , hbsag, anti-hepatitis b core antigen, or other active infection uncontrolled by treatment
boolean
C0220847 (UMLS CUI [1,1])
C0205160 (UMLS CUI [1,2])
C0019168 (UMLS CUI [2])
C0312631 (UMLS CUI [3])
C0009450 (UMLS CUI [4,1])
C0205318 (UMLS CUI [4,2])
Abstinence donating blood | Investigational New Drugs Therapeutic procedure
Item
agree to abstain from donating blood while taking study drug therapy and for one week following discontinuation of study drug therapy
boolean
C3843422 (UMLS CUI [1,1])
C0425264 (UMLS CUI [1,2])
C0013230 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
Sharing Investigational New Drugs | Return to investigator Investigational New Drugs Not used
Item
agree not to share study medication with another person and to return all unused study drug to the investigator
boolean
C0237876 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0332156 (UMLS CUI [2,1])
C0035173 (UMLS CUI [2,2])
C0013230 (UMLS CUI [2,3])
C0445107 (UMLS CUI [2,4])
Informed Consent
Item
written informed concent
boolean
C0021430 (UMLS CUI [1])
Mental disorders Compliance behavior Limited
Item
psychiatric illness or condition which could interfere with the subjects' ability to understand the requirements of the study
boolean
C0004936 (UMLS CUI [1,1])
C1321605 (UMLS CUI [1,2])
C0439801 (UMLS CUI [1,3])
nervous system disorder Interferes with Study Protocol | Neuropsychiatric syndrome Interferes with Study Protocol
Item
neurological or neuropsychiatric disorder, interfering with the requirements of the study
boolean
C0027765 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,3])
C3203509 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C2348563 (UMLS CUI [2,3])
hearing impairment
Item
hearing impairment over grade 2
boolean
C1384666 (UMLS CUI [1])
Porphyria
Item
porphyria
boolean
C3463940 (UMLS CUI [1])
Hepatitis
Item
history of acute or chronic hepatitis
boolean
C0019158 (UMLS CUI [1])
FH: Hepatitis Drug-Induced Hepatitis Severe
Item
family history of severe drug-induced hepatitis
boolean
C0559141 (UMLS CUI [1,1])
C1262760 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,3])
Pregnancy | Breast Feeding
Item
pregnancy and lactation
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])